Another example is that the bioactive natural product honokiol downregulates miR-188-5p and further attenuates the inhibition of the FBXW7/c-MYC axis, thus increasing doxorubicin sensitivity in BC cells (195). The gene discussed is MYC; the disease is breast cancer.